These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 7922783)
1. Human recombinant interleukin-1 receptor antagonist blocks bone resorption induced by interleukin-1 beta but not interleukin-1 alpha. Chole RA; Tinling SP; Faddis BT Calcif Tissue Int; 1994 Jul; 55(1):12-5. PubMed ID: 7922783 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 receptor antagonist inhibits the hypercalcemia mediated by interleukin-1. Guise TA; Garrett IR; Bonewald LF; Mundy GR J Bone Miner Res; 1993 May; 8(5):583-7. PubMed ID: 8511985 [TBL] [Abstract][Full Text] [Related]
3. In vivo inhibition of localized bone resorption by human recombinant interleukin-1 receptor antagonist. Chole RA; Faddis BT; Tinling SP J Bone Miner Res; 1995 Feb; 10(2):281-4. PubMed ID: 7754808 [TBL] [Abstract][Full Text] [Related]
4. Persistent bone-sparing effect of interleukin-1 receptor antagonist: a hypothesis on the role of IL-1 in ovariectomy-induced bone loss. Kimble RB; Kitazawa R; Vannice JL; Pacifici R Calcif Tissue Int; 1994 Oct; 55(4):260-5. PubMed ID: 7820776 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. Kitazawa R; Kimble RB; Vannice JL; Kung VT; Pacifici R J Clin Invest; 1994 Dec; 94(6):2397-406. PubMed ID: 7989596 [TBL] [Abstract][Full Text] [Related]
6. Mouse interleukin-1 receptor antagonist induced by Actinobacillus actinomycetemcomitans lipopolysaccharide blocks the effects of interleukin-1 on bone resorption and osteoclast-like cell formation. Nishihara T; Ohsaki Y; Ueda N; Saito N; Mundy GR Infect Immun; 1994 Feb; 62(2):390-7. PubMed ID: 8300200 [TBL] [Abstract][Full Text] [Related]
7. Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production. Seckinger P; Klein-Nulend J; Alander C; Thompson RC; Dayer JM; Raisz LG J Immunol; 1990 Dec; 145(12):4181-4. PubMed ID: 2147937 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. Kimble RB; Vannice JL; Bloedow DC; Thompson RC; Hopfer W; Kung VT; Brownfield C; Pacifici R J Clin Invest; 1994 May; 93(5):1959-67. PubMed ID: 8182127 [TBL] [Abstract][Full Text] [Related]
9. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist. Simón C; Frances A; Piquette GN; el Danasouri I; Zurawski G; Dang W; Polan ML Endocrinology; 1994 Feb; 134(2):521-8. PubMed ID: 8299552 [TBL] [Abstract][Full Text] [Related]
10. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors. Torcia M; Lucibello M; Vannier E; Fabiani S; Miliani A; Guidi G; Spada O; Dower SK; Sims JE; Shaw AR; Dinarello CA; Garaci E; Cozzolino F Exp Hematol; 1996 Jul; 24(8):868-74. PubMed ID: 8690044 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of 3,5,3'-triiodothyroacetic acid and triiodothyronine on bone resorption in cultured fetal rat long bones and neonatal mouse calvariae. Kawaguchi H; Pilbeam CC; Woodiel FN; Raisz LG J Bone Miner Res; 1994 Feb; 9(2):247-53. PubMed ID: 8140938 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells. Conti P; Feliciani C; Barbacane RC; Panara MR; Reale M; Placido FC; Sauder DN; Dempsey RA; Amerio P Immunology; 1992 Oct; 77(2):245-50. PubMed ID: 1427978 [TBL] [Abstract][Full Text] [Related]
14. Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage. Abramson SB; Amin A Rheumatology (Oxford); 2002 Sep; 41(9):972-80. PubMed ID: 12209029 [TBL] [Abstract][Full Text] [Related]
15. Natural and recombinant interleukin 1 receptor antagonist does not inhibit human T-cell proliferation induced by mitogens, soluble antigens or allogeneic determinants. Nicod LP; el Habre F; Dayer JM Cytokine; 1992 Jan; 4(1):29-35. PubMed ID: 1535518 [TBL] [Abstract][Full Text] [Related]
16. The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra). Swiergiel AH; Smagin GN; Johnson LJ; Dunn AJ Brain Res; 1997 Nov; 776(1-2):96-104. PubMed ID: 9439800 [TBL] [Abstract][Full Text] [Related]
17. The effect of IL-1 receptor antagonist on the proliferation of hematopoietic progenitor cells in regenerating bone marrow. Jovcić G; Ivanović Z; Biljanović-Paunović L; Bugarski D; Stosić-Grujicić S; Milenković P Leukemia; 1996 Mar; 10(3):564-9. PubMed ID: 8642876 [TBL] [Abstract][Full Text] [Related]
18. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism]. Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587 [TBL] [Abstract][Full Text] [Related]
19. The interleukin-1 receptor antagonist and its delivery by gene transfer. Evans CH; Robbins PD Receptor; 1994; 4(1):9-15. PubMed ID: 8038709 [TBL] [Abstract][Full Text] [Related]
20. The search for inhibitors of interleukin-1 based on the sequence of interleukin-1 receptor antagonist. Wieczorek Z; Kluczyk A; Slon-Usakiewicz JJ; Siemion IZ Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(4):123-9. PubMed ID: 9575352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]